Rafael Hernani

Valencia, VC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

TAFRO-like syndrome associated with long-term CAR-T cell persistence after axicabtagene ciloleucel therapy.

TAFRO-like syndrome associated with long-term CAR-T cell persistence after axicabtagene ciloleucel therapy.

Journal: Haematologica

Published: May 27, 2026

Regulatory challenges of personalized medicine in the real world: are the right patients being treated with CD19-targeting CAR T-cells?

Regulatory challenges of personalized medicine in the real world: are the right patients being treated with CD19-targeting CAR T-cells?

Journal: EMBO molecular medicine

Published: December 04, 2025

SARS-CoV-2 spike-directed T cells and anti-receptor-binding-domain antibodies in hematological patients receiving three mRNA COVID-19 vaccine doses.

SARS-CoV-2 spike-directed T cells and anti-receptor-binding-domain antibodies in hematological patients receiving three mRNA COVID-19 vaccine doses.

Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)

Published: November 05, 2025

Microbiome-Based Modeling of CAR-T Therapy Response in Lymphoma: Insights From Shotgun Metagenomics Sequencing.

Microbiome-Based Modeling of CAR-T Therapy Response in Lymphoma: Insights From Shotgun Metagenomics Sequencing.

Journal: European journal of haematology

Published: September 25, 2025

EASIX Does Not Add Prognostic Value Beyond Lactate Dehydrogenase and ECOG Performance Status in CAR T-Cell Therapy: A GETH-TC Study.

EASIX Does Not Add Prognostic Value Beyond Lactate Dehydrogenase and ECOG Performance Status in CAR T-Cell Therapy: A GETH-TC Study.

Journal: Transplantation and cellular therapy

Published: August 07, 2025

Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients: The Experience of the Grupo Español de Trasplante Hematopoyético y Terapia Celular.

Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients: The Experience of the Grupo Español de Trasplante Hematopoyético y Terapia Celular.

Journal: Transplantation

Published: June 17, 2025

Corrigendum to: "Comparison of three strategies of GvHD prophylaxis after T-cell replete haploidentical hematopoietic transplantation: Tacrolimus vs calcineurin inhibitors-MMF vs sirolimus-MMF" Journal: Transplant Cell Ther. 2024 Oct;30(10):1025.e1-1025.e14. doi: 10.1016/j.jtct.2024.07.027.

Corrigendum to: "Comparison of three strategies of GvHD prophylaxis after T-cell replete haploidentical hematopoietic transplantation: Tacrolimus vs calcineurin inhibitors-MMF vs sirolimus-MMF" Journal: Transplant Cell Ther. 2024 Oct;30(10):1025.e1-1025.e14. doi: 10.1016/j.jtct.2024.07.027.

Journal: Transplantation and cellular therapy

Published: June 14, 2025

Patient selection and treatment outcomes over time in patients with large B-cell lymphoma receiving car T-cell therapy.

Patient selection and treatment outcomes over time in patients with large B-cell lymphoma receiving car T-cell therapy.

Journal: Bone marrow transplantation

Published: May 30, 2025

Pre-infusion cytomegalovirus T-cell immunity for predicting the risk of virus DNAemia in patients undergoing chimeric antigen receptor T-cell therapies.

Pre-infusion cytomegalovirus T-cell immunity for predicting the risk of virus DNAemia in patients undergoing chimeric antigen receptor T-cell therapies.

Journal: British journal of haematology

Published: May 14, 2025

Patterns of immune recovery after axicabtagene ciloleucel for aggressive B-cell lymphoma.

Patterns of immune recovery after axicabtagene ciloleucel for aggressive B-cell lymphoma.

Journal: HemaSphere

Published: May 14, 2025

Prospective evaluation of CAR-T cell therapy-related proteinuria and kidney dysfunction.

Prospective evaluation of CAR-T cell therapy-related proteinuria and kidney dysfunction.

Journal: Clinical kidney journal

Published: May 06, 2025

Neutralizing Antibody and T-Cell Spike Targeted Responses Following Receipt of a Monovalent Omicron JN.1-Adapted mRNA COVID-19 Vaccine in Immunosuppressed and Healthy Individuals.

Neutralizing Antibody and T-Cell Spike Targeted Responses Following Receipt of a Monovalent Omicron JN.1-Adapted mRNA COVID-19 Vaccine in Immunosuppressed and Healthy Individuals.

Journal: Journal of medical virology

Published: May 05, 2025

Showing 1-12 of 68

Last Updated: 09/26/2026